Teachers as health promoters: a longitudinal study of the effect of a health education curriculum for trainee teachers on their practice in schools

Overview of attention for article published in The Lancet, April 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#47 of 22,007)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
40 news outlets
blogs
17 blogs
twitter
614 tweeters
facebook
120 Facebook pages
wikipedia
1 Wikipedia page
googleplus
8 Google+ users
reddit
2 Redditors

Readers on

mendeley
323 Mendeley
Title
Teachers as health promoters: a longitudinal study of the effect of a health education curriculum for trainee teachers on their practice in schools
Published in
The Lancet, April 2015
DOI 10.1016/s0140-6736(14)62222-4
Pubmed ID
Authors

Willem Kuyken, Rachel Hayes, Barbara Barrett, Richard Byng, Tim Dalgleish, David Kessler, Glyn Lewis, Edward Watkins, Claire Brejcha, Jessica Cardy, Aaron Causley, Suzanne Cowderoy, Alison Evans, Felix Gradinger, Surinder Kaur, Paul Lanham, Nicola Morant, Jonathan Richards, Pooja Shah, Harry Sutton, Rachael Vicary, Alice Weaver, Jenny Wilks, Matthew Williams, Rod S Taylor, Sarah Byford, Kuyken, Willem, Hayes, Rachel, Barrett, Barbara, Byng, Richard, Dalgleish, Tim, Kessler, David, Lewis, Glyn, Watkins, Edward, Brejcha, Claire, Cardy, Jessica, Causley, Aaron, Cowderoy, Suzanne, Evans, Alison, Gradinger, Felix, Kaur, Surinder, Lanham, Paul, Morant, Nicola, Richards, Jonathan, Shah, Pooja, Sutton, Harry, Vicary, Rachael, Weaver, Alice, Wilks, Jenny, Williams, Matthew, Taylor, Rod S, Byford, Sarah

Abstract

Individuals with a history of recurrent depression have a high risk of repeated depressive relapse or recurrence. Maintenance antidepressants for at least 2 years is the current recommended treatment, but many individuals are interested in alternatives to medication. Mindfulness-based cognitive therapy (MBCT) has been shown to reduce risk of relapse or recurrence compared with usual care, but has not yet been compared with maintenance antidepressant treatment in a definitive trial. We aimed to see whether MBCT with support to taper or discontinue antidepressant treatment (MBCT-TS) was superior to maintenance antidepressants for prevention of depressive relapse or recurrence over 24 months. In this single-blind, parallel, group randomised controlled trial (PREVENT), we recruited adult patients with three or more previous major depressive episodes and on a therapeutic dose of maintenance antidepressants, from primary care general practices in urban and rural settings in the UK. Participants were randomly assigned to either MBCT-TS or maintenance antidepressants (in a 1:1 ratio) with a computer-generated random number sequence with stratification by centre and symptomatic status. Participants were aware of treatment allocation and research assessors were masked to treatment allocation. The primary outcome was time to relapse or recurrence of depression, with patients followed up at five separate intervals during the 24-month study period. The primary analysis was based on the principle of intention to treat. The trial is registered with Current Controlled Trials, ISRCTN26666654. Between March 23, 2010, and Oct 21, 2011, we assessed 2188 participants for eligibility and recruited 424 patients from 95 general practices. 212 patients were randomly assigned to MBCT-TS and 212 to maintenance antidepressants. The time to relapse or recurrence of depression did not differ between MBCT-TS and maintenance antidepressants over 24 months (hazard ratio 0·89, 95% CI 0·67-1·18; p=0·43), nor did the number of serious adverse events. Five adverse events were reported, including two deaths, in each of the MBCT-TS and maintenance antidepressants groups. No adverse events were attributable to the interventions or the trial. We found no evidence that MBCT-TS is superior to maintenance antidepressant treatment for the prevention of depressive relapse in individuals at risk for depressive relapse or recurrence. Both treatments were associated with enduring positive outcomes in terms of relapse or recurrence, residual depressive symptoms, and quality of life. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme, and NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula.

Twitter Demographics

The data shown below were collected from the profiles of 614 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 323 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 8 2%
Netherlands 3 <1%
Denmark 2 <1%
Spain 2 <1%
United States 2 <1%
Germany 1 <1%
Australia 1 <1%
Brazil 1 <1%
Ireland 1 <1%
Other 8 2%
Unknown 294 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 75 23%
Student > Master 50 15%
Student > Ph. D. Student 46 14%
Student > Bachelor 37 11%
Other 36 11%
Other 79 24%
Readers by discipline Count As %
Psychology 148 46%
Medicine and Dentistry 86 27%
Social Sciences 29 9%
Agricultural and Biological Sciences 16 5%
Nursing and Health Professions 10 3%
Other 34 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 948. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2017.
All research outputs
#1,540
of 7,436,043 outputs
Outputs from The Lancet
#47
of 22,007 outputs
Outputs of similar age
#74
of 200,993 outputs
Outputs of similar age from The Lancet
#2
of 392 outputs
Altmetric has tracked 7,436,043 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,007 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,993 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 392 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.